Development of a controlled-release anti-parkinsonian nanodelivery system using levodopa as the active agent
Aminu Umar Kura,1 Samer Hasan Hussein Al Ali,2 Mohd Zobir Hussein,3 Sharida Fakurazi,1,4 Palanisamy Arulselvan11Laboratory of Vaccine and Immunotherapeutics, Institute of Bioscience, 2Laboratory of Molecular Biomedicine, Institute of Bioscience, 3Materials Synthesis and Characterization Laboratory,...
Guardado en:
Autores principales: | Kura AU, Hussein Al Ali SH, Hussein MZ, Fakurazi S, Arulselvan P |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2013
|
Materias: | |
Acceso en línea: | https://doaj.org/article/deb146a12f2b4caa8d2ad73ffec45c3e |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Anticancer nanodelivery system with controlled release property based on protocatechuate–zinc layered hydroxide nanohybrid
por: Barahuie F, et al.
Publicado: (2014) -
Preparation and controlled-release studies of a protocatechuic acid-magnesium/aluminum-layered double hydroxide nanocomposite
por: Barahuie F, et al.
Publicado: (2013) -
Development of a biocompatible nanodelivery system for tuberculosis drugs based on isoniazid-Mg/Al layered double hydroxide
por: Saifullah B, et al.
Publicado: (2014) -
Controlled-release approaches towards the chemotherapy of tuberculosis
por: Saifullah B, et al.
Publicado: (2012) -
Development of antiproliferative nanohybrid compound with controlled release property using ellagic acid as the active agent
por: Hussein MZ, et al.
Publicado: (2011)